Back

Persistent serpinA3 and periostin levels after TAVR: a reverse cardio-oncology perspective

18 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Biomarkers Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Timea Balint

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

37 More presentations in this session

Presentation thumbnail
Conditions mimicking obesity result in mitochondrial dysfunction in three-dimensional in vitro cardiovascular spheroid models
Doctor M. Blignaut (Cape Town, ZA)
Abstract
Presentation thumbnail
Evaluation of bile-scid profiles and functional capacity before and after bariatric surgery
Doctor S. Wolf (Graz, AT)
Abstract
Presentation thumbnail
Multiomics of maladaptive cardiac energy metabolism in the progression of multimorbid cardiovascular disease
Doctor D. Bernieh (Leicester, GB)
Abstract
Presentation thumbnail
Unraveling the role of iron in the heart using 3D engineered heart tissue
Mr S. Majoor (Groningen, NL)
Abstract
Presentation thumbnail
Designing and development of a novel efflux assay based on liposome and macrophage to evaluate hdl's reverse cholesterol transport capacity
Miss S. Varshney (New Delhi, IN)
Abstract

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

18 April 2026 08:30 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources